0
0
Read Time:14 Second
Emcure Pharmaceuticals Limited has informed the Exchange regarding ‘Intimation under Regulation 31A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Outcome of the meeting of the Board of Directors considering requests for re-classification from the Promoter and Promoter Group category to Public category’. |SUBJECT: Updates
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %
